[DOI] [PMC free article] [PubMed] [Google Scholar] 86.Franz M.J., VanWormer J.J., Crain A.L., Boucher J.L., Histon T., Caplan W., Bowman J.D., Pronk N.P
GLP-1 medications affect people differently
Brand Medications: What You Need to Know Compounded semaglutide and tirzepatide from licensed 503A pharmacies follow the same FDA monographs and quality standards as their brand counterparts, ensuring equivalent safety and efficacy profiles
GLP-1 receptor agonists, particularly semaglutide and tirzepatide, have fundamentally changed how patients and prescribers approach metabolic health and weight management
This landscape features major pharmaceutical companies developing GLP-1 therapies, service providers supporting clinical trials, regulatory agencies overseeing safety and efficacy, and end users such as hospitals, clinics, and home care settings
Nausea: One of the most common side effects of GLP-1 receptor agonists is nausea